214 related articles for article (PubMed ID: 12964069)
1. Lapatinib ditosylate GlaxoSmithKline.
Kim TE; Murren JR
IDrugs; 2003 Sep; 6(9):886-93. PubMed ID: 12964069
[TBL] [Abstract][Full Text] [Related]
2. BAY-43-9006 Bayer/Onyx.
Lee JT; McCubrey JA
Curr Opin Investig Drugs; 2003 Jun; 4(6):757-63. PubMed ID: 12901237
[TBL] [Abstract][Full Text] [Related]
3. BMS-247550 Bristol-Myers Squibb/GBF.
Lin N; Brakora K; Seiden M
Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
[TBL] [Abstract][Full Text] [Related]
4. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
Medina PJ; Goodin S
Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
[TBL] [Abstract][Full Text] [Related]
5. 109881 Aventis.
Ojima I; Geney R
Curr Opin Investig Drugs; 2003 Jun; 4(6):737-40. PubMed ID: 12901234
[TBL] [Abstract][Full Text] [Related]
6. Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors.
Nelson MH; Dolder CR
Ann Pharmacother; 2006 Feb; 40(2):261-9. PubMed ID: 16418322
[TBL] [Abstract][Full Text] [Related]
7. MEN-10755. Menarini.
Jones K
Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
[TBL] [Abstract][Full Text] [Related]
8. ZD-6126 AstraZeneca.
Soltau J; Drevs J
IDrugs; 2004 Apr; 7(4):380-7. PubMed ID: 15057644
[TBL] [Abstract][Full Text] [Related]
9. Lerisetron. FAES.
Huckle R
Curr Opin Investig Drugs; 2003 Jul; 4(7):874-7. PubMed ID: 14619411
[TBL] [Abstract][Full Text] [Related]
10. CKD-602. Chong Kun Dang.
Crul M
Curr Opin Investig Drugs; 2003 Dec; 4(12):1455-9. PubMed ID: 14763132
[TBL] [Abstract][Full Text] [Related]
11. CMT-3. CollaGenex.
Fingleton B
Curr Opin Investig Drugs; 2003 Dec; 4(12):1460-7. PubMed ID: 14763133
[TBL] [Abstract][Full Text] [Related]
12. Arzoxifene Eli Lilly.
Marchisano-Karpman C; DeGregorio MW
IDrugs; 2003 Sep; 6(9):880-5. PubMed ID: 12964068
[TBL] [Abstract][Full Text] [Related]
13. Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib.
Burris HA
Oncologist; 2004; 9 Suppl 3():10-5. PubMed ID: 15163842
[TBL] [Abstract][Full Text] [Related]
14. Diflomotecan. Ipsen.
Osheroff N
IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
[No Abstract] [Full Text] [Related]
15. TLK-286.
Verschraegen CF; Smith HO; Lee FC; Cathcart C; Norenberg JP
IDrugs; 2004 Aug; 7(8):771-81. PubMed ID: 15334311
[TBL] [Abstract][Full Text] [Related]
16. AE-941 (AEterna).
Dredge K
Curr Opin Investig Drugs; 2004 Jun; 5(6):668-77. PubMed ID: 15242256
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
Halterman PA
Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
[TBL] [Abstract][Full Text] [Related]
18. Ganstigmine. Chiesi.
Johnson A
Curr Opin Investig Drugs; 2003 Jul; 4(7):868-73. PubMed ID: 14619410
[TBL] [Abstract][Full Text] [Related]
19. Lapatinib-associated toxicity and practical management recommendations.
Moy B; Goss PE
Oncologist; 2007 Jul; 12(7):756-65. PubMed ID: 17673607
[TBL] [Abstract][Full Text] [Related]
20. Nemifitide. Innapharma.
Dingemanse J
Curr Opin Investig Drugs; 2003 Jul; 4(7):859-62. PubMed ID: 14619408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]